Medical imaging and radiology
Aidoc
Clinical AI platform for radiology and enterprise imaging workflows.
Last updated: June 5, 2026
Back to directoryiCAD ProFound AI medical AI product profile
Breast health AI suite for mammography detection, scoring, density assessment, and risk-related workflows.
Medical imaging and radiology
Best fit
Breast imaging programs comparing AI assistance for 2D mammography, digital breast tomosynthesis, case prioritization, and mammography workflow support.
- Primary use case
- AI-assisted breast cancer detection, mammography case scoring, density assessment, and short-term risk workflow support
- Audience
- Breast imaging centers, radiology groups, hospitals, and mammography programs
- Risk level
- High
- Pricing signal
- Enterprise breast-imaging pricing; verify current modules, clearances, viewer compatibility, and service terms.
- Official sources
- 4 official sources
Compare within workflow: Medical imaging and radiology · comparison shortlist · source index
Regulatory, privacy, evidence, and workflow lens
Product-specific review. These product-specific signals summarize what the cited sources imply before treating iCAD ProFound AI as safe for a local clinical, operational, or research workflow.
| Regulatory / FDA | Verify the exact ProFound module and version because FDA-cleared detection, density, and risk-related features do not share one blanket authorization. |
|---|---|
| Privacy | Review mammography image routing, DICOM metadata handling, PACS/viewer integration, cloud or local deployment, retention, access controls, and security documentation. |
| Evidence | Check reader-study evidence, breast-density subgroup performance, recall impact, cancer subtype detection, specificity, and whether priors are used in the selected version. |
| Workflow | Map where marks, case scores, density output, risk signals, and worklist prioritization appear in the radiologist workflow before clinical use. |
Where iCAD ProFound AI fits
iCAD describes ProFound breast-health AI for 2D and 3D mammography detection, density, scorecard, and risk-related workflows; its product and FDA-clearance materials distinguish cleared detection products from risk features that require product-specific status review.
Not for: Using risk, density, or detection claims interchangeably across products, geographies, exam types, or U.S. intended-use limits.
What to verify before using iCAD ProFound AI
- Which module is in scope: ProFound Detection, ProFound AI for DBT, density assessment, risk scoring, or another breast-health workflow.
- FDA clearance, CE mark, Health Canada status, and U.S. investigational limitations for the exact module and version.
- Compatibility with mammography vendor, PACS/viewer workflow, priors, worklist prioritization, and radiologist review process.
- Local performance across breast density, cancer subtype, recall rate, false positives, false negatives, and reading-time impact.
Source links
Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.
- www.icadmed.com / breast-health
- www.icadmed.com / profound-detection-v4-0
- www.icadmed.com / about / news-events
- www.icadmed.com / wp-content / uploads
Related medical AI products
Medical imaging and radiology
Viz.ai
AI-powered care coordination platform with imaging-driven alerts across therapeutic areas.
Medical imaging and radiology
Ferrum Health
Clinical AI governance and deployment platform for health systems adopting multiple imaging or clinical AI models.
Medical imaging and radiology
Blackford Platform
Enterprise medical imaging AI platform for evaluating, deploying, routing, and monitoring multiple radiology AI applications.